Open AccessDexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
Author(s) -
Min Seok Kim,
Jasmine S Choi,
Hyeong Du Lee,
Se Joon Woo
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s302014
Subject(s) - medicine , macular edema , branch retinal vein occlusion , implant , ophthalmology , visual acuity , dexamethasone , central retinal vein occlusion , adverse effect , post hoc analysis , subgroup analysis , retinal vein , surgery , confidence interval
To supplement established efficacy and safety data, this analysis evaluated the real-world use of dexamethasone (DEX) intravitreal implant 700 µg for retinal vein occlusion (RVO)-related macular edema in an Asian population and baseline factors potentially associated with DEX implant efficacy.